Business
Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln
Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln
About this update from Infant Bacterial Therapeutics Ab Class B
Infant Bacterial Therapeutics AB OMXSTO:IBT_B:Q4 OPERATING INCOME KSEK -20,538* (-37,445)
View stock analysis, news, and events for Infant Bacterial Therapeutics Ab Class B